Collaboration can fix ‘broken’ clinical trials model TransCelerate CEO tells CROs
Collaboration does not mean drugmakers have started playing nice, it’s just that the pain of shared problems has become unbearable according to TransCelerate Biopharma CEO, Dalvir Gill.